BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11365645)

  • 1. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
    Fichtenbaum CJ
    Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
    Jacobson MA; French M
    AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
    Green H; Hay P; Dunn DT; McCormack S;
    HIV Med; 2004 Jul; 5(4):278-83. PubMed ID: 15236617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections: an update.
    Furrer H; Fux C
    J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
    Jubault V; Pacanowski J; Rabian C; Viard JP
    Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of opportunistic infections in the protease inhibitor era].
    Viciana P; Miralles-Martín P; Knobel H; Gatell JM
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():1-10. PubMed ID: 9859614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping preventive treatments.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
    Powderly WG
    Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary complications in patients with AIDS].
    Oka S
    Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 15. Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.
    Aberg JA
    AIDS Clin Rev; 2000-2001; ():115-38. PubMed ID: 10999219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
    Currier JS
    AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good news about HIV treatments.
    Treat Rev; 1998; (No 28):3. PubMed ID: 11365424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
    Gill J; Moyle G; Nelson M
    AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
    [No Abstract]   [Full Text] [Related]  

  • 19. Pneumocystis carinii pneumonia.
    Schliep TC; Yarrish RL
    Semin Respir Infect; 1999 Dec; 14(4):333-43. PubMed ID: 10638513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.